Renal Insufficiency and the Risk of Infection from Pacemaker or Defibrillator Surgery
- 20 February 2006
- journal article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 29 (2) , 142-145
Abstract
Background: Pacemakers and implanted cardioverter defibrillator (ICD) infection rates are rising. Renal insufficiency impairs immune function and is known to increase the risk of infection following implantation of orthopedic hardware. The purpose of the current study is to characterize the risk factors for pacemaker and ICD infection and to evaluate the role of renal insufficiency in this complication. Methods and Results: A large (n = 4,856) single center experience with pacemaker and ICD procedures was reviewed. Of these, 141 were extractions of infected devices and 76 of these patients had been implanted in the Emory system and had preimplant creatinine information available for analysis. These cases were compared to 76 control patients undergoing device implantation matched by date of implant who had no infective complications. Demographic and clinical data from both groups were compared using both univariate and multivariate analysis. The overall rate of infection was 1.5%. Patients with device infection were more likely to have congestive heart failure (CHF), be diabetic, have generator exchanges, and to take warfarin than controls. There was no difference in the prevalence of coronary disease, atrial fibrillation, steroid use, or malignancy between the two groups. Elevated creatinine (Cr ≥1.5 mg/dL) was much more frequent in patients with infection than in controls (38% vs 12%, odds ratio 4.6, P < 0.001). Moderate to severe renal disease (GFR ≤60 cc/min/1.73 m2) was the most potent risk factor for infection, with a prevalence of 42% in infected patients versus 13% in controls (odds ratio of 4.8). Conclusions: Renal insufficiency dramatically increases the risk of infection complicating pacemaker or ICD surgery. This association should be part of the risk‐benefit consideration prior to device implantation. Additional study of more extensive perioperative antibiotic therapy in this subset of patients is warranted.Keywords
This publication has 19 references indexed in Scilit:
- Pacemaker Endocarditis in Patients with Prosthetic Valve Replacements: Case Trilogy and Literature ReviewPacing and Clinical Electrophysiology, 2007
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureNew England Journal of Medicine, 2004
- Increasing rates of cardiac device infections among medicare beneficiaries: 1990–1999American Heart Journal, 2004
- Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularizationJournal of Vascular Surgery, 2004
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- TablesAmerican Journal of Kidney Diseases, 2002
- Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiencyKidney International, 1999
- Systemic Infection Related to Endocarditis on Pacemaker LeadsCirculation, 1997
- Infections in Implantable Cardioverter Defibrillator PatientsPacing and Clinical Electrophysiology, 1990